Interest in psychedelic-assisted therapy has grown rapidly over the past several years. While substances such as MDMA-assisted therapy and psilocybin therapy are still undergoing regulatory review and clinical trials, ketamine therapy is already being used in clinical settings across the United States, including California. Many people exploring psychedelic therapy in California are interested in understanding how these treatments differ and what options may currently be available.
Ketamine therapy is often discussed alongside emerging psychedelic treatments because it can produce altered states of consciousness and has shown promise for certain mental health conditions. However, it also differs in important ways from therapies currently being studied with substances like MDMA and psilocybin. Individuals researching psychedelic therapy in San Diego or psilocybin therapy in Los Angeles are often trying to understand how ketamine compares with these emerging treatments.
This guide explains what ketamine therapy is, how it works, and how it fits into the broader landscape of psychedelic-assisted treatments in California.
What Is Ketamine Therapy?
Ketamine is a medication originally developed in the 1960s and approved by the U.S. Food and Drug Administration (FDA) as an anesthetic. For decades it has been widely used in surgical and emergency medicine.
In more recent years, researchers and clinicians have explored ketamine’s potential effects on mental health conditions such as:
• Depression
• Post-traumatic stress disorder (PTSD)
• Anxiety disorders
• Chronic pain conditions
Unlike many traditional psychiatric medications that may take weeks to produce noticeable effects, ketamine can sometimes produce rapid changes in mood and perception, which has led to growing interest in its therapeutic potential.
Today, ketamine may be administered in controlled medical environments under professional supervision. In some cases, a related medication called esketamine (Spravato®) has received FDA approval for treatment-resistant depression when used with medical monitoring.
How Ketamine Therapy Works
Ketamine works differently from most traditional antidepressant medications. Instead of primarily affecting serotonin levels, ketamine acts on the brain’s glutamate system, which plays a role in neural communication and plasticity.
Researchers believe ketamine may help by:
• Promoting new neural connections
• Interrupting rigid patterns of negative thinking
• Increasing neuroplasticity, the brain’s ability to adapt and reorganize
When used in a therapeutic setting, ketamine may be combined with psychotherapy or integration support, helping patients process insights or emotional experiences that occur during treatment.
The exact structure of ketamine therapy programs can vary, but they often involve:
• Initial screening and medical evaluation
• A supervised treatment session
• Post-session integration or therapeutic support
Because ketamine can affect perception and awareness, these sessions are typically conducted in a controlled clinical environment.
Is Ketamine Therapy Legal in California?
Yes. Ketamine can be legally prescribed by licensed medical professionals in California when used in accordance with existing medical regulations.
There are two primary pathways through which ketamine may be used:
- Off-label ketamine therapy
Physicians may prescribe ketamine “off-label” for certain mental health conditions. Off-label prescribing is common in medicine and occurs when a medication is used for a purpose other than its original FDA-approved indication. - Esketamine (Spravato®)
Esketamine is an FDA-approved nasal spray derived from ketamine that is used specifically for treatment-resistant depression. It must be administered in certified medical facilities under supervision.
Because regulations and treatment models can vary, individuals considering ketamine therapy should always consult qualified medical professionals for evaluation and guidance.
How Ketamine Differs From Psychedelic-Assisted Therapy
Although ketamine is sometimes grouped with psychedelic treatments, it differs in several key ways from substances such as MDMA and psilocybin.
Regulatory Status
Ketamine is already legally available through medical providers. In contrast, MDMA and psilocybin remain under federal review and are primarily used in clinical trials or regulated research settings. Interest in MDMA therapy in the Bay Area and psilocybin therapy in California has grown significantly as research continues to expand.
Treatment Models
Ketamine therapy often involves a series of sessions administered by medical providers, sometimes paired with psychotherapy.
In contrast, emerging psychedelic therapies being studied with MDMA or psilocybin typically involve a more structured model that includes:
• Extended preparation sessions
• One or two supervised dosing sessions
• Multiple integration sessions afterward
These models are still being evaluated in clinical trials.
Psychological Experience
Ketamine can produce altered perceptions, but the experience is often described differently from classic psychedelic substances.
Psilocybin and MDMA therapy sessions may involve deep emotional processing and extended therapeutic sessions lasting several hours, while ketamine sessions are typically shorter and structured differently depending on the clinical protocol.
Safety and Clinical Oversight
As with any medical or psychological treatment, safety and proper screening are essential.
Ketamine therapy should only be considered under the supervision of qualified medical professionals who can evaluate:
• Medical history
• Mental health conditions
• Potential contraindications
• Medication interactions
Responsible treatment environments typically include:
• Licensed clinicians or physicians
• Careful patient screening
• Structured treatment protocols
• Integration or follow-up support
Individuals should avoid unregulated or unsupervised environments when considering treatments that affect consciousness or mental health.
The Growing Landscape of Psychedelic Medicine
Ketamine therapy is part of a broader wave of research into psychedelic-assisted treatments. Over the past decade, studies have explored the therapeutic potential of several substances, including:
- MDMA-assisted therapy for PTSD
• Psilocybin therapy for depression and end-of-life anxiety
• Psychedelic-assisted therapy models for addiction and trauma
Interest in psychedelic therapy in Southern California, including San Diego psychedelic therapy programs, continues to increase as research expands.
Looking Ahead
Ketamine therapy represents one of the earliest examples of how altered-state therapies may be integrated into modern mental health care.
As research continues and regulatory frameworks evolve, additional treatments such as MDMA-assisted therapy and psilocybin therapy may eventually become available through regulated clinical pathways.
For individuals interested in the future of psychedelic-assisted therapy in California, staying informed about ongoing research, clinical trials, and regulatory developments can be helpful.
Staying Informed About Psychedelic Therapy Developments
The landscape of psychedelic medicine is changing quickly. New clinical trials, regulatory decisions, and treatment models continue to emerge.
People researching psilocybin therapy in Los Angeles, MDMA therapy in the Bay Area, or psychedelic therapy in San Diego are often looking for responsible information about how these treatments may evolve in the coming years.
Understanding how these therapies work—and how they differ—can help individuals make more informed decisions as the field continues to evolve.
Regional Psychedelic Therapy Guides
Learn more about psychedelic-assisted therapy across California:
• Psychedelic Therapy in San Diego
• Psilocybin Therapy in Los Angeles
• MDMA Therapy in the Bay Area